Thailand's home-grown Covid-19 vaccine to start production first quarter 2022

Image from The Nation Thailand/ANN

BANGKOK, Nov 20 (Bernama): Thailand’s Chulalongkorn University is expected to start the production of its mRNA Covid-19 vaccine, ChulaCov19, in the first quarter of next year.

Head of the Covid-19 vaccine development project Dr Kiat Ruxrungtham said ChulaCov19 will enter its third phase of human trials, with jabs scheduled to be administered in the first quarter of 2022 as well.

He said an application will be filed with the Thai Food and Drug Administration (FDA) mid-next year for emergency use.

"If the vaccine registration is approved (by FDA), the research team is required to conduct fourth phase trials to gather information about the vaccine's safety and effectiveness from some 30,000 recipients,” he said, as quoted by Bangkok Post.

Meanwhile, Kiat said the research team has begun developing the second generation of ChulaCov19.

He said the research team has started trials on mice, while trials on the vaccine’s effectiveness as booster dose is also being conducted.

In August, Kiat said ChulaCov19 vaccine generates immunity on par with the Pfizer-BioNTech and Moderna mRNA vaccine and provides protection against the four major variants of Covid-19 - Alpha, Beta, Gamma and Delta.

Earlier this month, the Cabinet approved 2.32 billion baht (100baht = RM12.78) to support the development of the ChulaCov19 vaccine. - Bernama

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Thailand , Covid-19 , Vaccine , ChulaCov19 , mRNA


Next In Aseanplus News

Deadly fire prompts anger
DPM gets key party role as succession advances
Macau casino giants win licence renewals, Malaysia's Genting loses bid
Soccer-Australia's Duke treasures special goal celebration dedicated to young son
Asean News Headlines at 9pm on Saturday (Nov 26, 2022)
Indonesia’s six-month plan for investment opportunities for transition to renewable energy
Bukit Jalil a hive of activity ahead of Malaysia Cup final
Singapore reports 1,290 new Covid-19 cases and no new deaths on Saturday (Nov 26)
Experts in Indonesia say that Cianjur quake points to fact that urgent improvement needed in disaster mitigation flaws
Still no late nights out in Thailand ... Proposal to let nightspots remain open till 4am rejected

Others Also Read